Sugi Predict

Sugi Predict / Compounds / SCHEMBL202181

SCHEMBL202181

SCHEMBL202181

Nc1nc2cc(O)ccc2c2c1nc1n2CCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 10/20 0.41
▸ ALDH1A1 P00352 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ CASP1 P29466 2/20 0.37
▸ CASP7 P55210 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ KMT2A Q03164 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.32
▸ TLR8 Q9NR97 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ GLA P06280 1/20 0.31
▸ RAD52 P43351 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ ROCK1 Q13464 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL202167 0.86 PIK3CA (0.38) TLR7KMT2ATLR8PIK3CA
SCHEMBL203310 0.79 PARP14 (0.40) TLR7KMT2ATLR8
SCHEMBL311967 0.76 ALDH1A1 (0.42) TLR7ALDH1A1GAAHPGDCASP1
SCHEMBL1232440 0.70 TLR7 (0.39) TLR7ALDH1A1GAAHPGDCASP1
SCHEMBL29729430 0.70 KMT2A (0.39) ALDH1A1GAAHPGDCASP1CASP7
SCHEMBL1233100 0.68 TLR7 (0.40) TLR7ALDH1A1GAAHPGDCASP1
SCHEMBL1775932 0.64 TLR7 (0.41) TLR7ALDH1A1GAAHPGDCASP1
SCHEMBL1061674 0.64 MEN1 (0.50) TLR7ALDH1A1HPGDCASP1CASP7
SCHEMBL4242646 0.63 TLR7 (0.61) TLR7TLR8
SCHEMBL16705242 0.63 TLR7 (0.69) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
WO-2007106852-A2 SUBSTITUTED FUSED[1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 — — WO disclosed
WO-2007106852-A2 SUBSTITUTED FUSED[1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS IL2, IFNG, IL4 TLR7 69/4885ALDH1A1 979/4885GAA 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.